David Ross,David Siegel,Wenchang Guo,Christopher J. Moody,Christopher S.P. McErlean
申请号：
US12673996
公开号：
US20120022011A1
申请日:
2008.08.22
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention provides purified 19-substituted geldanamycin derivatives, pharmaceutically acceptable salts thereof and prodrugs thereof that are potent Hsp90 binding agents that are useful for the treatment and/or the amelioration of symptoms of cancer and other proliferative tissue disorders.
